Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImage Scan Holdings Regulatory News (IGE)

Share Price Information for Image Scan Holdings (IGE)

Share Price is delayed by 15 minutes
Get Live Data
2.05    0.00 (0.00%)
Bid:
1.90
Ask:
2.20
Spread: 0.30 (15.789%)
Market Cap: £2.81m
IGE Live PriceLast checked at - London Stock Exchange

Intraday Image Scan Holdings Share Chart

New Rapiscan Agreement

21 Oct 2005 06:00

For immediate release: 0700hrs Friday 21st October 2005 IMAGE SCAN HOLDINGS PLC ANNOUNCES NEW AGREEMENT WITH RAPISCAN SYSTEMS LIMITED FOR 2D AND 3D TECHNOLOGY Image Scan Holdings plc (AIM: IGE), a provider of leading real-time multi-view,3D X-ray imaging solutions for the industrial and security inspection markets,today confirmed that it has signed a new agreement with Rapiscan SystemsLimited which optimises the synergy between the two companies. This newagreement includes an immediate order valued at ‚£345,000 for 3D imagingcomponents and on-going research into advanced 3D technologies which isscheduled to be fulfilled by February 2006. The agreement supersedes theprevious agreement signed in February 2004.The disappointing sales performance of the 3DSP and 3DLP (3D baggage X-rayscreening systems) due to significant price pressure within the sector led to ajoint review of the sales and marketing strategy. As a consequence of thesediscussions a new agreement has been established that will provide for both amore cost effective business model for the 3D technology and the opportunityfor Rapiscan to take advantage of some of Image Scan's recent advances in X-rayproducts for security applications.Rapiscan, who retain an exclusive licence to market some of Image Scan's 3Dproducts within the security sector, can now benefit from advances in ImageScan's technology that will enable them to re-launch the 3D baggage inspectionsystem at a more competitive price.Nicholas Fox, Chief Executive of Image Scan Holdings plc, commented:"We believe that having worked closely with Rapiscan over recent years we havenow found the right formula for success. Rapiscan remain committed to our 3DX-ray technology and we look forward to a growing return on our investment inthis sector. Rapiscan's significant new order for our 3D equipment kick startsthis growth with the commitment to our 2D technology providing furtheropportunities."Frank Baldwin, Managing Director of Rapiscan Systems Limited, commented:"We are delighted to have reached this new agreement with Image Scan. Ourcommitment to their 2D and 3D technology is strong and we believe that withthis new cost model we should see improved sales for these products developover the next few months. This combination of technology will strengthenRapiscan's competitive position while providing increased sales volume andrevenue growth for Image Scan."About Image Scan Holdings plcImage Scan Holdings plc (AIM: IGE) is focused on the development andcommercialisation of market leading real-time 3D and 2D X-ray solutions for usein the global industrial and security inspection markets. The company'sindustrial inspection solutions include the MDXI unit and the X-line camera.The company's security inspection solutions currently feature the unique 3Dbaggage inspection system, AXIS-3D‚®, marketed by Rapiscan in their 3DSP and3DLP product lines. For further information on the company, please visit www.ish.co.uk - and for further information on its products, please visit www.3dx-ray.com.--- ENDS ---For further information, please contact:Image Scan Holdings Tel: 01664 503 600Nicholas Fox, CEOGTH Media Relations Tel: 020 7153 8039 / 8035Toby Hall / Jade MamarbachiRapiscan Systems Limited Tel: +44 (0)870 777 4301Frank Baldwin, MDENDIMAGE SCAN HOLDINGS PLC
Date   Source Headline
5th Jun 20269:45 amRNSContract Award
30th Apr 20267:00 amRNSInterim Results
25th Feb 20262:27 pmRNSResult of AGM
25th Feb 20267:00 amRNSAGM Statement
2nd Feb 20267:00 amRNSUpdate on Defence Contract with NP Aerospace
21st Jan 20261:31 pmRNSNotice of AGM and Posting of Annual Report
2nd Dec 20257:00 amRNSFinal Results
18th Nov 20257:00 amRNS-RContract Award
11th Nov 20257:00 amRNSNew Contract Award
4th Nov 20257:00 amRNSTrading Update
2nd Sep 202511:23 amRNSHolding(s) in Company
21st Aug 20257:00 amRNSTrading Update And New Contract Awards
20th May 20258:32 amRNSInterim Results
14th May 202511:55 amRNSHolding(s) in Company
26th Feb 20252:38 pmRNSResult of AGM
26th Feb 20257:00 amRNSAGM Statement
15th Jan 202510:48 amRNSNotice of AGM & Posting of Annual Report
3rd Dec 20247:00 amRNSFinal Results
23rd Oct 20247:00 amRNSTrading Update
16th Oct 20247:00 amRNSContract Award Update
4th Sep 20247:00 amRNSHolding(s) in Company
21st Aug 20247:00 amRNSHolding(s) in Company
7th Aug 20247:00 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20247:00 amRNSChange of Adviser
4th Jul 20247:00 amRNSContract Award
12th Jun 20247:00 amRNSContract award worth over £350k
20th May 20244:33 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSInterim Results
29th Apr 20247:00 amRNSInitial c£300k order for new Portable X-Ray System
12th Mar 20247:00 amRNSLaunch of AXIS-CXi Cabinet with AI Software
28th Feb 20242:48 pmRNSResult of AGM
28th Feb 20247:00 amRNSTrading Statement
26th Jan 20241:50 pmRNSHolding(s) in Company
18th Jan 20241:28 pmRNSHolding(s) in Company
11th Jan 20243:06 pmRNSHolding(s) in Company
9th Jan 202412:46 pmRNSNotice of AGM & Posting of Annual Report
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
12th Dec 20237:00 amRNSFinal Results
10th Oct 20237:00 amRNSTrading Update
11th Sep 20237:00 amRNS2023 orders to over 30 countries
4th Jul 20237:00 amRNSHolding(s) in Company
26th Apr 20237:00 amRNSInterim Results
13th Mar 20239:34 amRNSHolding(s) in Company
28th Feb 20233:03 pmRNSResult of AGM
28th Feb 20237:00 amRNSTrading Statement
10th Feb 20231:26 pmRNSHolding(s) in Company
26th Jan 202312:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.